We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Help improve GOV.UK Sign up to take part in user research (opens in a new tab)
VDEC works with global leaders from all sectors to develop and deliver the vaccine and therapeutic products we need to protect us from infectious diseases.
The pre-clinical evaluation team at VDEC provides a safe and controlled environment to test new vaccines and therapeutics before they progress to clinical trials
Guidance for organisations involved in any aspect of the pharmaceutical lifecycle or GLP studies regulated by MHRA, covering the approval of paper documents when working from home
How the MHRA assesses marketing authorisation applications (MAA) for medicines referred under Article 29.
If pharmacies wish to ‘pack down’ larger packs of a medicinal product, they need to follow these instructions
Guidance for manufacturers of coronary stents. It outlines specific scenarios that should be considered when determining if an incident is reportable.
Guidance for manufacturers of artificial heart valves. It outlines specific scenarios that should be considered when determining if an incident is reportable.
Guidance and specifications for the recording and extraction of CTAD data from laboratories in England processing LA and NHS commissioned chlamydia tests.
Which submission type to select when submitting a notification of intent to market e-cigarette and vape products in Northern Ireland.
An initiative to help drive advancements in healthcare, to ensure patients benefit from innovation and new treatments sooner.
summary
Sets out opportunities for commissioners and providers to realise community pharmacy’s role in protecting and improving the nation's health.
On this page the Medicines and Healthcare Products Regulatory agency provides advice for producers of E-cigarette/vape products
An overview of the five technologies selected for the AI Airlock pilot.
The call for applications for phase 2 of the AI Airlock is now closed.
Access Consortium Statement on Good Manufacturing Practice (GMP) Inspections Reliance and Recognition
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2021.
Expansion of extra-jurisdictional inspection outcomes.
Information on how the ACBS factors in the issue of pricing, when reviewing product applications.
A set of principles for understanding the impact of new variants on antiviral drugs and monoclonal antibodies
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).